Publish date: 1 July 2022
Przeczytasz w 2 min
The 38th edition of the European Society of Human Reproduction and Embryology (ESHRE) Congress will begin in just two days. It is one of the most important events in the field of reproductive medicine, where experts from all over Europe exchange knowledge and discuss the results of the latest scientific research. This year, the Congress will take place from July 3rd to July 6th in Milan, and of course, our representation will be present.
Due to the pandemic situation, the last two editions of the ESHRE Congress were held fully online. This year, the organizers have decided to return to the format of in-person meetings, offering participants the option to attend the Congress on-site or remotely.
Taking advantage of this opportunity, some members of the INVICTA Group’s delegation will be present in Milan, while others will join online. The INVICTA Group’s CEO, a delegation of doctors, embryologists, the Research and Development Center, and the Medical Diagnostic Laboratories will represent us during ESHRE.
This year, as part of the event, the scientific team of INVICTA will present the results of ongoing scientific projects and interesting findings from research, showcasing two abstracts that will be featured in the ESHRE poster session. The topics of our abstracts are:
Detecting gene variants correlated with MII oocytes developed during ovarian stimulation
S. Pukszta1, K. Zieliński2, P. Wygocki3,4, M. Zieleń4, J. Jakóbkiewicz-Banecka5, A. Kloska5.
The impact of clinical factors on the number of MII oocytes
K. Zieliński1, D. Drzyzga1, P. Wygocki2,3, M. Zieleń3, J. Liss1,4.
We believe that participating in ESHRE will be an opportunity for our delegation to exchange knowledge and experiences, as well as establish new connections.
